Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor
Kadono, S., Sakamoto, A., Kikuchi, Y., Oh-eda, M., Yabuta, N., Yoshihashi, K., Kitazawa, T., Suzuki, T., Koga, T., Hattori, K., Shiraishi, T., Haramura, M., Kodama, H., Ono, Y., Esaki, T., Sato, H., Watanabe, Y., Itoh, S., Ohta, M., Kozono, T.(2005) Biochem Biophys Res Commun 327: 589-596
- PubMed: 15629154 
- DOI: 10.1016/j.bbrc.2004.12.042
- Primary Citation of Related Structures:  
1WUN, 1WV7 - PubMed Abstract: 
Selective factor VIIa-tissue factor complex (FVIIa/TF) inhibition is seen as a promising target for developing new anticoagulant drugs. Structure-based designs of the P3 moiety in the peptide mimetic factor VIIa inhibitor successfully lead to novel inhibitors with selectivity for FVIIa/TF and extrinsic coagulation the same as or even higher than those of previously reported peptide mimetic factor VIIa inhibitors ...